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31P NMR spectroscopy investigation of muscle metabolism in hemodi-
alysis patients. Calf muscle metabolism of six patients with end-stage
chronic renal failure undergoing maintenance hemodialysis and of six
control subjects was studied using 31P nuclear magnetic resonance
spectroscopy at 4.7 Tesla. Spectra were obtained at rest, during
exercise and recovery. At rest, the inorganic phosphate, ATP and
phosphocreatine concentrations, and the intracellular pH were similar
in both groups of subjects. In the patients, the maximum workload
achieved at the end of exercise led to a 84% and 46% depletion of
phosphocreatine and ATP, respectively; under this condition, the
intracellular pH fell to 6.50 0.09. In control subjects, a maximum
workload caused no change in ATP concentration at the end of
exercise, but a phosphocreatine depletion and an intracellular pH fall
similar to those observed in the patients. Although the rate of phospho-
creatine depletion during exercise was not different in the two groups of
subjects, the decrease in intracellular pH was more rapid in the patients
than in control subjects. At the end of maximum exercise, the rates of
recovery of both phosphocreatine and intracellular pH were signifi-
cantly reduced in the muscle of hemodialysis patients when compared
to normal subjects. These results suggest that, in the calf muscle of
hemodialysis patients, energy production via oxidative metabolism is
impaired and compensated for by an increase in anaerobic glycolysis.
Muscle weakness is a common symptom in patients with
chronic renal failure; most of these patients complain of easy
fatigability and exercise intolerance [1]. These abnormalities of
muscle function in chronic renal failure, which are accompanied
by atrophy of type I and type II muscle fibers [2—4], have been
attributed to various factors such as disturbances of muscle
energy metabolism resulting from altered muscle blood flow [41,
diminished oxygen supply to muscle due to anemia, defective
muscle metabolism of amino acids [5, 6], insulin resistance
leading to a reduction of muscle glucose utilization as energy
source [7], peripheral neuropathy [1, 3], impaired metabolism of
vitamin D and excess of parathyroid hormone [81. The latter
hormone, which has been implicated in the reduction of car-
nitine palmitoyl transferase activity in muscle of rats in chronic
renal failure [91, might be responsible for a diminished supply of
energy (in the form of fatty acids) to muscle cells.
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Thus, many interrelated factors whose relative importance
remains undefined appear to be potentially involved in the
alterations of muscle bioenergetics underlying the exercise
intolerance observed in patients with chronic renal failure. To
our knowledge, only few data about the characteristics of the
alterations of the metabolism of the energy-rich phosphorylated
compounds involved in skeletal muscle bioenergetics are avail-
able [5, 10]. We have therefore used phosphorus nuclear
magnetic resonance spectroscopy (31P MRS), a noninvasive
tool which has been extensively employed in recent years to
investigate metabolic processes related to muscle function in
normal [11, 121, and inherited [131 or acquired [14] pathological
situations, to examine call muscle energy metabolism in hemo-
dialysis patients and normal subjects at rest, during exercise as
well as during the recovery phase.
The results suggest that, together with the expected decrease
in exercising capacity, a deficit of oxidative energy metabolism
and a stimulation of anaerobic glycolysis are present in skeletal
muscle of patients with chronic renal failure who are undergo-
ing hemodialysis.
Methods
Subjects
Six patients (3 male and 3 female) with end-stage renal failure
(plasma creatinine = 970 78 tmol/liter; mean SEM),
currently on center hemodialysis, participated in the study upon
informed consent. Their original disease diagnoses were
chronic glomerulonephntis (N = 2), membranous nephropathy
(N = 1), tubular interstitial nephritis (N = 2) and nephroangio-
sclerosis [1]. Patients with diabetic nephropathy, cardiac ar-
rythmia or failure, emphysema, secondary hyperparathyroid-
ism or with medication of steroids, NSAID were excluded from
the study. None had thyroid or hepatic disease. All patients had
chronic metabolic acidosis (serum bicarbonate < 21 mmollliter)
documented for at least six months before their inclusion into
the study and all had severe anemia (hemoglobin concentration
<10 gldl). Their mean age was 50.6 14.3 years (range 31 to 77
years). All were receiving hemodialysis three times weekly with
a bicarbonate-containing bath during their participation in this
study. The mean duration from their onset of dialysis was 65.5
5.0 months (range 22 to 156 months). Each patient was
investigated on a day between two dialysis sessions.
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Six age and sex matched (3 male and 3 female; mean age 47.8
6.4 years, range 28 to 77 years), healthy sedentary volunteers
with normal renal function served as controls.
31P NMR spectroscopy
31P NMR spectroscopy was performed with a Fourier trans-
form Bruker MSL 200 spectrometer interfaced with a 4.7 Tesla,
40-cm bore superconducting magnet (Oxford Magnet Technol-
ogy, Oxford, UK) operating at resonance frequencies of 81.04
and 200.2 MHz for 31P and 1H, respectively.
The subjects were studied in the supine position, the calf
muscle of the dominant leg laying over a 5-cm home-built
double tuned surface coil. A sliding bed was used to move the
patient's leg in the center of the magnet. Inside the magnet
cavity, the sole of the subject's foot rested on a movable foot
plate placed at 90 degrees with respect to the long axis of the
leg. The foot plate was itself connected by a lever to an
ergometer loaded with a weight of 10 kg, corresponding to a
force of 98.1 N. Any pressure exerted by the subject's foot on
the foot plate was opposed by the load. Work, expressed in
Joules, was calculated as the product of the load by its
displacement multiplied by the frequency of pedalling, the pedal
movement being linked to a measuring table with a displace-
ment transducer and the pedal frequency being transmitted to a
graphic recorder.
Magnetic field homogeneity was optimized while observing
the water proton signal, and a proton spectrum was collected (4
transients, repetition time 5 seconds, pulse width = 200
second); the peak half width at half height never exceeded 35
Hz. Then, a control 31P spectrum, which served as the baseline
value, was collected for each individual study at rest (64
transients using an excitation pulse of 220 second and a
repetition rate of 7 seconds). During the exercise protocol,
spectra were recorded with a pulse repetition of 2.2 seconds and
a pulse width of 220 jssecond. Eight scans were collected over
a total acquisition time of 17.5 seconds yielding a time resolu-
tion of approximately 3 spectra per minute.
Signal intensities of phosphocreatine, inorganic phosphate
and 13-ATP, which were quantitated relative to an external
reference signal (methylene diphosphonic acid), were obtained
by computer integration after phase and baseline correction of
the spectra. The areas were corrected for incomplete saturation
at the pulse conditions chosen and, assuming an intracellular
water volume content of 0.67 ml per g wet weight of muscular
tissue [15], the concentrations of the energy-rich phosphate
metabolites were expressed in m per liter of intracellular
water.
Intracellular pH was calculated using the following form of
the Henderson-Hasselbalch equation: pH = 6.75 + log [(3 —
3.27)1(5.69 — 3)1, where 3 indicates the chemical shift difference
(in ppm) between the inorganic phosphate and the phosphocre-
atine peaks.
Exercise protocol
After measuring the control spectrum at rest, each control
subject and patient was asked to perform a maximum exercise.
For this, each control subject and patient had to press on the
pedal at a regular frequency (2 Hz) and to maintain the isotonic
contractions of his calf muscle as long as possible until exhaus-
tion. Call muscle discomfort and a drop in rate or displacement
were the determinants for terminating the exercise. Each con-
trol subject was also ask to mimick the exercise protocol
performed by the corresponding patient.
Statistical analysis
The results are expressed as means SEM. The unpaired
Student's t-test was used to compare values obtained in the
patients with those of the controls. A P value < 0.05 was
considered significant. The least-squares method was used to
test the existence of a linear correlation: (i) between the
decrease in intracellular pH or in phosphocreatine concentra-
tion and time of exercise, (ii) between the increase in intracel-
lular pH and time of recovery after exercise.
Results
Spectra of muscle at rest
The 31P NMR spectra of the resting calf muscle of one normal
subject and one hemodialysis patient are shown in Figures 1 and
2, respectively. It can be seen that, at the high field strength (4.7
T) used, the peaks observed were extremely well separated and
that the signal-to-noise ratio was high. This allowed accurate
measurements of the different peak areas. From left to right,
resonances are assigned to methylene diphosphonic acid, phos-
phomonoesters, inorganic phosphate (which increased during
exercise), phosphodiesters, phosphocreatine (which declined
during exercise), and the three ATP resonances of which only
the f3 resonance was used to calculate ATP concentration
because it did not contain the ADP and NAD/NADP reso-
nances. In most cases, the phosphomonoester peak was not
seen.
Table 1 shows the intracellular pH values and the absolute
concentrations of phosphocreatine, inorganic phosphate and
ATP as well as the phosphocreatine/inorganic phosphate ratio,
which is related to the phosphate potential [16, 17], in calf
muscles of the control and hemodialysis subjects at rest. It can
be seen that these parameters in hemodialysis subjects were not
different from those in the controls.
Exercise studies
Figures 3 and 4 show 28 spectra (out of 40 obtained for each
subject) from a typical sequence obtained in one control subject
and one hemodialysis patient at rest (spectra 1—4), during
exercise until exhaustion (spectra 5—15 in the control subject,
and 5—17 in the patient) and subsequent recovery (spectra 16—28
in the control subject, and 18—28 in the patient). As can be seen
in these figures, the high field strength of our magnet allowed to
obtain high signal-to-noise ratios and an excellent temporal
resolution (one spectrum every 17.5 seconds). As expected,
there was a net degradation of phosphocreatine to inorganic
phosphate during exercise and, at the end of exercise, both
inorganic phosphate and phosphocreatine concentrations re-
turned rapidly towards resting values.
Figure 5 shows the changes of workload, phosphocreatine
concentration and intracellular pH over eight 17.5-second inter-
vals of maximum exercise for all control subjects and hemodi-
alysis patients. It can be seen that the rate of phosphocreatine
depletion observed in the patients was similar to that in the
control subjects. When the phosphocreatine concentration (C),
expressed in percent of its resting value, was plotted as a
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Fig. 1. A 31P MRS spectrum from calf muscle
of a normal subject at rest. Abbreviations are:
MDPA, methylene diphosphonic acid; PME,
phosphomonoesters; Pi, inorganic phosphate;
'Cr phosphocreatine; y-, a- and /3-ATP = the
a- and f3-phosphate of adenosine
o —io PPM triphosphate.
Table 1. Concentrations of phosphate metabolites and intracellular
pH values in calf muscle of control and hemodialysis subjects at rest
Control subjects(N=6) Hemodialysis subjects(N=6)
pH 7.02 0.01 7.01 0.01
PcrmM 28.9±3.1 31.8±4.8
PimM 2.4 0.3 2.8 0.7
Pc_/Pi 12.9 1.3 12.3 0.7
ATPmM 5.2±1.5 4.4±0.9
The values, expressed in mM/liter of muscle intracellular water, were
obtained using a 7 second pulse interval and corrected for saturation
effects. They are given as means SEM. No statistical difference was
found between the control and hemodialysis subjects. Abbreviations
are: phosphocreatine; Pi, inorganic phosphate.
function of time (t, expressed in 17.5 second intervals), the
equation obtained in control subjects (C = — 9.Olt + 101.93;
r 0.97) and that obtained in hemodialyzed patients (C = —8.7t
+ 97.04; r = 0.93) revealed no statistically significant differ-
ence.
After an initial increase due to the consumption of protons by
the creatine kinase reaction operating in the direction of phos-
phocreatine utilization, the intracellular pH fell in both groups
of subjects (Fig. 5). When the pH (P), expressed in pH units,
was plotted as a function of time (t) from the second to the
eighth 17.5 second intervals of intense exercise, the equations
obtained in the hemodialysis patients (P = —0.08t + 7.26; r =
0.97) and in the control subjects (P = —0.06t + 7.31; r = 0.96)
Cr
MDPA
Pi
czATP
I I I I I I
3ATP
30 20 10
Cr
Pi ATP
I I I I I I I I I
30 20 10 0 —10 PPM
Fig. 2. A 31P MRS spectrum from calf muscle of a hemodialysis patient
at rest. For peak assignments, see Fig. 1.
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Fig. 3. Stackedplot from a maximum
exercise in a representative control subject.
Spectra 1—4 (rest), 5—15 (exercise until
exhaustion) and 16—28 (recovery). For peak
assignments, see Fig. 1.
Fig. 4. Stacked plot from a maximum
exercise in a hemodialysis patient. Spectra
1—4 (rest), 5—17 (exercise until exhaustion) and
18—28 (recovery). For peak assignments, see
Fig. 1.
indicate that the intracellular pH declined more rapidly (P <
0.001) in the patients than in the normal subjects.
Table 2 shows the metabolic changes observed at the end of
the maximum exercise carried out by the hemodialysis and the
control subjects. It also shows the changes observed at the end
of the exercise performed by the control subjects to mimick the
maximum exercise of the hemodialysis patients.
The workload needed to reach muscle exhaustion in patients
corresponded to a moderate exercise in the control subjects
who did not experience fatigue. This workload did not alter the
intracellular pH and led to only a 39% depletion of phospho-
creatine in healthy subjects.
On the average, the workload needed to produce muscle
exhaustion in the control subjects was 7.4 times greater than in
the patients. At the end of maximum exercise, such a workload
led in the control subjects to a large phosphocreatine depletion
similar to that observed in hemodialysis subjects (Table 2). The
significant intracellular acidification due to accumulation of
lactic acid resulting from anaerobic glycolysis was of similar
magnitude in both groups of subjects at the end of maximum
exercise. Muscle ATP concentration did not change in the
control subjects indicating that the ATP degraded during mus-
cle contraction was resynthesized thanks to the stimulation of
oxidative phosphorylation and to ATP synthesis by the creatine
kinase reaction (H + ADP + phosphocreatine — ATP +
creatine) as well as by the stimulation of anaerobic glycolysis
revealed by intracellular acidification when the concentration of
inorganic phosphate exceeded that of phosphocreatine. By
contrast, muscle ATP concentration was markedly diminished
at the end of the exercise in the patients (Table 2). However,
resting muscle ATP levels were found to be restored by the first
17.5 second interval of recovery from exercise in the patients.
Figure 6 shows the phosphocreatine concentration and intra-
cellular pH recovery after exercise. It can be seen that, despite
Pcr
1 Rest
16 Recovery
PCI
1 Rest
18 Recovery
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Table 2. Effect of exercise on intracellular pH, phosphocreatine depletion and resynthesis, and ATP depletion in calf muscle of control and
hemodialysis subjects
Exercise duration Total workload
Intracellular pH Phosphocreatine
depletiona
Phosphocreatine
resynthesis
ATP
depletionaAt the end
17.6 second intervals Joules At rest of exercise % of resting value T112 in seconds % of resting value
Control subjects 12.0 1.8 357 40 7.02 0.01 7.00 0.03 39.2 9.0 22.9 2.3 ND
(moderate exercise)
Hemodialysis subjects 12.0 1.8 321 451 7.01 0.01 6.50 0.09 84.7 2.0" 58.4 10.9" 46.5 9.8"
(maximum exercise)
Control subjects 13.6 1.2 2380 465 7.02 0.01 6.56 0.04 84.5 3.4 30.5 2.4 2.8 2.8
(maximum exercise)
Abbreviations are: ND, not determined; T112, time for recovery of 50% of the phosphocreatine depleted at the end of exercise. The values
obtained in 6 control and 6 hemodialysis subjects are given as means SEM. Statistical difference was measured by the unpaired Student's t-test
against the hemodialysis subjects.a at the end of exercise
b P < 0.05 vs. control subjects (maximum exercise)
a phosphocreatine depletion of similar magnitude in the control
and hemodialysis subjects at the end of exercise, the rate of
phosphocreatine concentration recovery was lower in the pa-
tients than in the control subjects. The time for recovery of half
the phosphocreatine broken down, which reflects the mitochon-
dna! oxidative metabolism [18], was considerably increased in
the hemodialysis patients indicating a deficient oxidative phos-
phorylation in these patients (Table 2). Another important
biochemical difference observed is that after an initial further
decrease in pH after the end of exercise (due to the accumula-
tion of part of the protons synthesized by the creatine kinase
reaction operating in the direction of phosphocreatine resynthe-
sis), the pH returned towards the resting value at a rate smaller
in the patients than in the normal subjects (P < 0.001). When
the pH (P), expressed in pH units, was plotted as a function of
time (t) from the second to the 15th 17.5 second intervals of
recovery in the control subjects and from the third to the 15th
17.5 second intervals of recovery in the patients, the equations
obtained were P 0.05t + 6.27 (r = 0.94) and P = 0.04t + 6.11
(r = 0.93), respectively.
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Fig. 5. Workload, phosphocreatine concentration and intracellular pH changes during eight 17.5-second intervals of maximum exercise in 6
control subjects (•) and 6 hemodialysis patients (0). Values are means SEM.
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exercise Recovery (bouts of 17.5 s)
Fig. 6. Phosphocreatine concentration and intracellular pH recovery
hemodialysis patients (0).
Discussion
In the present study, we used 31P MRS to determine if the
fatigability and exercise intolerance experienced by patients
with end-stage renal failure under maintenance hemodialysis is
associated with altered skeletal muscle metabolism. We evalu-
ated several variables central to muscle metabolism: the con-
centration of ATP, Cr and Pi, the PPi ratio, which is related
to the phosphorylation potential [ATP/(ADP+Pi)] [16, 17], and
intracellular pH which falls during exercise secondary to lactic
acid accumulation resulting from increased glycolysis when the
PlPi ratio decreases approximately below 1 [14].
The results obtained show that at rest, the concentrations of
the energy-rich phosphate metabolites and of Pi as well as the
intracellular pH in hemodialysis patients were not different
from those in normal subjects. Although our method of estima-
tion of the concentrations of the major phosphorus containing
compounds is not the most commonly one used [19], we
deliberately chose to estimate the absolute concentrations of
ATP, 'ICr and Pi by using methylene diphosphonic acid as the
external standard to be able to compare their concentrations in
patients with those in control subjects. This seemed more
appropriate than to use, as is most commonly done [19], muscle
ATP concentration as the standard without being certain that
this concentration in calf muscle of hemodialysis patients was
normal. An important point to consider is whether or not the
surface coil examined the same muscle mass in patients and
normal subjects. That this was indeed the case is suggested by
the absence of difference between the normal and hemodialysis
subjects in the water-to-fat ratio estimated from the signals
obtained in the 'H spectra. This ratio was equal to 2.9 0.7 in
the control subjects versus 3.0 0.8 (NS) in the patients. It
should be mentioned that the increase in extracellular water
content observed in muscle of hemodialysis patients [20] cannot
have significantly diminished muscle intracellular water mass
that has been examined in our patients compared to control
subjects, because extracellular water represents only a small
fraction (<10%) of total muscle water content [15].
By contrast, our study clearly establishes that muscle metab-
olism in hemodialysis subjects was markedly different from that
in control subjects during both exercise and recovery from
exercise. Although the maximal workload achieved by the
patients, which represented a very moderate workload for the
control subjects (Table 2), led to a depletion of phosphocreatine
of similar magnitude in both groups of subjects, a significant
decrease in ATP was found at the end of the maximum exercise
in patients but not in the control subjects. Such an ATP
depletion is known to occur in healthy subjects only during
extremely vigourous exercises leading to more than 90% Cr
depletion [21]. In addition, the rate of intracellular acidification
was found to be higher in the control subjects than in the
hemodialysis patients (Fig. 5, text). This suggests that the
stimulation of anaerobic glycolysis due to the recruitement of
muscle glycolytic fibers, which occurs predominantly when the
workload is sufficiently raised [221 and leads to the production
of large amounts of lactic acid, was greater in the patients than
in the normal subjects. All these abnormalities together with the
delayed recovery of 1Cr at the end of exercise, which has also
been observed in various other pathological states such as
mitochondrial myopathies [23], heart failure [14], peripheral
vascular insufficiency [24] and chronic respiratory failure [25]
are consistent with an impaired muscle resynthesis, by the
mitochondrial oxidative phosphorylation, of the ATP used for
muscular contraction. Such a reduced resynthesis of ATP
would in turn lead to a delayed resynthesis of pc. by creatine
kinase catalyzing the following reaction:
ATP+Cr — Pcr+ADP+H.
It is difficult from our results to identify the precise mecha-
nisms responsible for a diminished muscular resynthesis of ATP
in our patients. On the basis of data available in the literature,
a reduced mitochondrial population or efficiency can be ruled
out since the number of mitochondria in muscle of patients
suffering from chronic renal failure has been found normal [10]
and an increased oxidative capacity of these isolated mitochon-
dria has also been observed [4, 10]. Therefore, it is more likely
that the abnormalities observed resulted from a diminished
substrate supply or to a reduced oxygen delivery secondary to
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after exercise. Results are SEM for 6 control subjects (•) and 6
Durozard Ct at: NMR spectroscopy and uremic muscle metabolism 891
anemia and/or to insufficient blood flow to the leg during
exercise.
It should be emphasized that no correlation was found in our
study between the degree of anemia and the time for recovery
of half the Cr broken down at the end of exercise, or between
the degree of anemia and the fall of ATP concentration at the
end of exercise. These results, however, do not rule out a role
of anemia per se in the muscle metabolism alterations observed
because the involvement of this factor may be obscured by that
of other factors, such as reduced substrate supply and insuffi-
cient blood flow.
It should be stressed that a significant reduction of muscle
blood flow has been demonstrated in patients with chronic renal
failure when compared to normal subjects [4]. The fact that the
deficient skeletal muscle vascularization found in peripheral
vascular disease has been shown to be associated with an
unchanged mitochondrial population and an increased oxidative
capacity [4, 10] is in favor of a major role of chronic underper-
fusion of working muscle in the metabolic disturbances found in
our hemodialysis patients.
The role of hormonal and nutritional factors contributing to a
reduced substrate supply to muscle cells in chronic renal failure
cannot be evaluated from the data of the present study. Simi-
larly, our results do not permit any conclusion about the
possible inhibition of muscle mitochondrial respiration by the
so-called uremic toxins to be drawn [26].
The reason why the intracellular pH returned towards resting
values much more slowly in the patients cannot be related to the
resynthesis of phosphocreatine (which is accompanied by the
synthesis of protons), because this resynthesis was faster in the
control than in the hemodialysis subjects. It is conceivable that
it was due to continued anaerobic glycolysis or to a decrease in
the muscle buffering capacity, or in the rate of export of protons
from muscle cells of hemodialysis patients. Finally, since
muscular fatigue has been related to the accumulation of
protons [27, 28], the large and early pH fall and the delayed
recovery of pH might be responsible, at least partially, for the
exercise intolerance in our patients.
In conclusion, our ability to demonstrate clear disturbances
of muscle metabolism in hemodialysis subjects due to 31P MRS
is clinically important. In addition to improving our understand-
ing of the biochemical basis of exercise intolerance in these
patients, this noninvasive tool offers the possibility to evaluate
various nutritional and therapeutic approaches liable to dimin-
ish their fatigability.
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